Comparison of KRAS Mutation Status with Clinical Parameters in Colon Adenocarcinoma
Author:
BOYLU Barış,TÜRKMEN Mustafa
Publisher
Karadeniz Fen Bilimleri Dergisi
Subject
Community and Home Care
Reference38 articles.
1. Abudabous, A., Drah, M., Aldehmani, M., Parker, I., & Alqawi, O. (2021). KRAS mutations in patients with colorectal cancer in Libya. Molecular and clinical oncology, 15(4), 197. https://doi.org/10.3892/mco.2021.2359. 2. Awidi, M., Ababneh, N., Shomaf, M., Al Fararjeh, F., Owaidi, L., AlKhatib, M., Al Tarawneh, B., & Awidi, A. (2019). KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan. PloS one, 14(12), e0226473. https://doi.org/10.1371/journal.pone.0226473 3. Babat, I., Polat, H., Umar Gursu, R., Bashan, Y., Kırık, A., Bektas, H., Sarı, S., & Usul Afşar, Ç. (2021). The effect of mutation status, pathological features and tumor location on prognosis ın patients with colorectal cancer. Revista da Associacao Medica Brasileira (1992), 67(2), 185–189. https://doi.org/10.1590/1806-9282.67.02.20200321. 4. Baskin, Y., Dagdeviren, Y. K., Calibasi, G., Canda, A. E., Sarioglu, S., Ellidokuz, H., & Oztop, I. (2014). KRAS mutation profile differences between rectosigmoid localized adenocarcinomas and colon adenocarcinomas. Journal of gastrointestinal oncology, 5(4), 265. 5. Belardinilli, F., Capalbo, C., Malapelle, U., Pisapia, P., Raimondo, D., Milanetti, E., Yasaman, M., Liccardi, C., Paci, P., Sibilio, P., Pepe, F., Bonfiglio, C., Mezi, S., Magri, V., Coppa, A., Nicolussi, A., Gradilone, A., Petroni, M., Di Giulio, S., Fabretti, F., … Giannini, G. (2020). Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer. Frontiers in oncology, 10, 560. https://doi.org/10.3389/fonc.2020.00560.
|
|